Showing 135 results
February 2023
-
Media Release
Novartis associates take on challenge to unblock barriers to better cardiovascular health
To help reduce the heavy burden of cardiovascular diseases (CVDs), Novartis launched the Unblocked movement for heart health – an initiative co-created with external stakeholders in the healthcare… -
Media Release
Novartis: Working with DOH and other partners to end leprosy
Novartis and the Novartis Foundation have been working with the Department of Health and other partners to eliminate leprosy for over 30 years. The Novartis Foundation focuses on influencing…
January 2023
-
Media Release
Achievements and Announcements
Careers
Novartis Healthcare Philippines recognized as a Top Employer for third consecutive year
Novartis Healthcare Philippines has been officially recognized by the Top Employers Institute as a Top Employer 2023 in the Philippines. To become recognized as a Top Employer, an organization… -
Media Release
Partnerships and Commitments
Breast Cancer
ICanServe, Taguig City, Dashlabs, Novartis launch data-digital project to support breast cancer control program
The ICanServe Foundation, City of Taguig, local healthcare software startup Dashlabs, and Novartis have launched the Circle of Life Data and Digital Infrastructure project to support the Ating…
November 2022
-
Media Release
Novartis partners with DOH, medical societies, hospitals to strengthen healthcare system and improve heart failure management in PH
In a developing country like the Philippines, where healthcare delivery is mostly paid through patients' out-of-pocket expenses, the economic burden of heart failure (HF), especially… -
Media Release
Novartis recognized for supporting eye health services amid pandemic
Novartis Healthcare Philippines was recognized by the National Committee for Sight Preservation (NCSP) for the company’s support to the NCSCP “Maging MATAlino”…
September 2022
-
Media Release
Philippine FDA approves Novartis drug, ribociclib, for advanced breast cancer in males
The Philippine Food and Drug Administration (FDA) has approved ribociclib for the treatment of metastatic breast cancer. Ribociclib in combination with an aromatase inhibitor or fulvestrant… -
Story
Novartis supports the Southeast Asian Breast Cancer Symposium
August 2022
-
Media Release
Alliance and Partnerships for Patient Innovation and Solutions (APPIS) Initiative announces winners of inaugural Innovator Program
The APPIS Innovator Program enables patient organizations across Asia Pacific, Middle East and Africa (APMA) to grow and scale existing patient programs. Winners receive financial support,… -
Media Release
Novartis hails Philippine FDA approval of brolucizumab treatment for age-related macular degeneration in time for Sight Saving Month
The Philippine Food and Drug Administration (FDA) has approved brolucizumab for the treatment of neovascular (wet) age-related macular degeneration (AMD). Wet AMD is the leading cause of severe…